507 related articles for article (PubMed ID: 27030526)
1. Management of neurogenic bladder in patients with multiple sclerosis.
Phé V; Chartier-Kastler E; Panicker JN
Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
[TBL] [Abstract][Full Text] [Related]
2. Lower urinary tract dysfunction in patients with multiple sclerosis.
Panicker JN; Fowler CJ
Handb Clin Neurol; 2015; 130():371-81. PubMed ID: 26003255
[TBL] [Abstract][Full Text] [Related]
3. [Neuro-urological dysfunction of the lower urinary tract in CNS diseases: pathophysiology, epidemiology, and treatment options].
Mehnert U; Nehiba M
Urologe A; 2012 Feb; 51(2):189-97. PubMed ID: 22331072
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and the neurogenic bladder.
Rashid TM; Hollander JB
Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):615-29. PubMed ID: 9894113
[TBL] [Abstract][Full Text] [Related]
5. Neurogenic lower urinary tract dysfunction.
Panicker JN; De Sèze M; Fowler CJ
Handb Clin Neurol; 2013; 110():209-20. PubMed ID: 23312642
[TBL] [Abstract][Full Text] [Related]
6. Neurogenic lower urinary tract dysfunction: evaluation and management.
Tudor KI; Sakakibara R; Panicker JN
J Neurol; 2016 Dec; 263(12):2555-2564. PubMed ID: 27401178
[TBL] [Abstract][Full Text] [Related]
7. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.
Panicker JN; Fowler CJ; Kessler TM
Lancet Neurol; 2015 Jul; 14(7):720-32. PubMed ID: 26067125
[TBL] [Abstract][Full Text] [Related]
8. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
[TBL] [Abstract][Full Text] [Related]
9. Vesical dysfunction in multiple sclerosis.
Gonor SE; Carroll DJ; Metcalfe JB
Urology; 1985 Apr; 25(4):429-31. PubMed ID: 3984135
[TBL] [Abstract][Full Text] [Related]
10. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
11. The management of paediatric neurogenic bladder: an approach in a resource-poor setting.
Maison POM; Lazarus J
Paediatr Int Child Health; 2017 Nov; 37(4):280-285. PubMed ID: 28714784
[TBL] [Abstract][Full Text] [Related]
12. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
[TBL] [Abstract][Full Text] [Related]
14. Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.
Panicker JN; de Sèze M; Fowler CJ
Clin Rehabil; 2010 Jul; 24(7):579-89. PubMed ID: 20584864
[TBL] [Abstract][Full Text] [Related]
15. The neurogenic bladder characteristics and treatment approaches in the patients with multiple sclerosis.
Erden E; Ersöz M; Tiftik T; Erden E
Mult Scler Relat Disord; 2022 Feb; 58():103439. PubMed ID: 34954652
[TBL] [Abstract][Full Text] [Related]
16. Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
Khavari R; Karmonik C; Shy M; Fletcher S; Boone T
J Urol; 2017 Feb; 197(2):438-444. PubMed ID: 27664581
[TBL] [Abstract][Full Text] [Related]
17. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
[TBL] [Abstract][Full Text] [Related]
18. The overactive bladder in multiple sclerosis.
Fingerman JS; Finkelstein LH
J Am Osteopath Assoc; 2000 Mar; 100(3 Suppl):S9-12. PubMed ID: 10763312
[TBL] [Abstract][Full Text] [Related]
19. Early urological care of patients with spinal cord injury.
Welk B; Schneider MP; Thavaseelan J; Traini LR; Curt A; Kessler TM
World J Urol; 2018 Oct; 36(10):1537-1544. PubMed ID: 29948046
[TBL] [Abstract][Full Text] [Related]
20. Neurogenic Bladder: Epidemiology, Diagnosis, and Management.
Panicker JN
Semin Neurol; 2020 Oct; 40(5):569-579. PubMed ID: 33065745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
